Cynthia A Jackevicius

Summary

Affiliation: Western University of Health Sciences
Country: USA

Publications

  1. ncbi request reprint Clinical outcomes of erythropoietin use in heart failure patients with anemia of chronic kidney disease
    Cynthia A Jackevicius
    College of Pharmacy, Western University of Health Sciences, Pomona, California Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, California Institute for Clinical Evaluative Sciences, Toronto, Canada Faculty of Medicine, University of Toronto, Institute for Health Policy, Management, and Evaluation, Toronto, Canada University Health Network, Toronto, Canada Electronic address
    J Card Fail 20:327-33. 2014
  2. pmc Enhanced Interaction between Warfarin and High-Dose Ketoconazole: A Case Report
    Cynthia A Jackevicius
    Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, CA 91766 1854, USA
    Case Report Med 2009:315687. 2009
  3. doi request reprint Cardiovascular outcomes after a change in prescription policy for clopidogrel
    Cynthia A Jackevicius
    Western University of Health Sciences, College of Pharmacy, 309 E Second St, Pomona, CA 91766, USA
    N Engl J Med 359:1802-10. 2008
  4. pmc Use of fibrates in the United States and Canada
    Cynthia A Jackevicius
    Department of Pharmacy Practice and Administration, Western University of Health Sciences, College of Pharmacy, 309 E Second St, Pomona, CA 91766, USA
    JAMA 305:1217-24. 2011
  5. pmc Long-term trends in use of and expenditures for cardiovascular medications in Canada
    Cynthia A Jackevicius
    Western University of Health Sciences, College of Pharmacy, Pomona, CA 91766, USA
    CMAJ 181:E19-28. 2009
  6. doi request reprint Use of ezetimibe in the United States and Canada
    Cynthia A Jackevicius
    University Health Network, Schulich Heart Centre, Toronto
    N Engl J Med 358:1819-28. 2008
  7. ncbi request reprint Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada
    Lingyun Lu
    Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, CA Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA
    Am Heart J 167:683-9. 2014
  8. ncbi request reprint Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis
    Mitesh Shah
    Divisions of Clinical Epidemiology and General Internal Medicine, McGill University Health Center, Montreal, Quebec, Canada M S, M A T, NE R, H B, L P _ Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, CA C A J Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada V E Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital McGill University, Montreal, Quebec, Canada M J E Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada K H H Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Canada Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada J V T and Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada H G
    Circulation 129:1196-203. 2014
  9. ncbi request reprint Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients
    Cynthia A Jackevicius
    University Health Network, Toronto, ON, Canada
    Pharmacoepidemiol Drug Saf 16:207-15. 2007
  10. doi request reprint Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction
    Cynthia A Jackevicius
    University Health Network and Department of Health Policy, Management, and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    Circulation 117:1028-36. 2008

Detail Information

Publications27

  1. ncbi request reprint Clinical outcomes of erythropoietin use in heart failure patients with anemia of chronic kidney disease
    Cynthia A Jackevicius
    College of Pharmacy, Western University of Health Sciences, Pomona, California Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, California Institute for Clinical Evaluative Sciences, Toronto, Canada Faculty of Medicine, University of Toronto, Institute for Health Policy, Management, and Evaluation, Toronto, Canada University Health Network, Toronto, Canada Electronic address
    J Card Fail 20:327-33. 2014
    ..This study assessed clinical outcomes associated with erythropoietin (EPO) treatment in this cardiorenal anemia syndrome (CRAS) population...
  2. pmc Enhanced Interaction between Warfarin and High-Dose Ketoconazole: A Case Report
    Cynthia A Jackevicius
    Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, CA 91766 1854, USA
    Case Report Med 2009:315687. 2009
    ....
  3. doi request reprint Cardiovascular outcomes after a change in prescription policy for clopidogrel
    Cynthia A Jackevicius
    Western University of Health Sciences, College of Pharmacy, 309 E Second St, Pomona, CA 91766, USA
    N Engl J Med 359:1802-10. 2008
    ....
  4. pmc Use of fibrates in the United States and Canada
    Cynthia A Jackevicius
    Department of Pharmacy Practice and Administration, Western University of Health Sciences, College of Pharmacy, 309 E Second St, Pomona, CA 91766, USA
    JAMA 305:1217-24. 2011
    ..The evidence for clinical benefit in outcomes with the use of fibrates is heavily weighted on the use of the older fibrates such as gemfibrozil and clofibrate...
  5. pmc Long-term trends in use of and expenditures for cardiovascular medications in Canada
    Cynthia A Jackevicius
    Western University of Health Sciences, College of Pharmacy, Pomona, CA 91766, USA
    CMAJ 181:E19-28. 2009
    ..We describe long-term trends in the use of and expenditures for cardiovascular medications in Canada, by drug class and by province...
  6. doi request reprint Use of ezetimibe in the United States and Canada
    Cynthia A Jackevicius
    University Health Network, Schulich Heart Centre, Toronto
    N Engl J Med 358:1819-28. 2008
    ..We sought to describe the adoption of ezetimibe relative to that of other lipid-lowering agents and compare its use in the two countries...
  7. ncbi request reprint Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada
    Lingyun Lu
    Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, CA Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA
    Am Heart J 167:683-9. 2014
    ..What is not known is how practice in the 2 countries changed after the ENHANCE trial. We examined ezetimibe use trends in the US and Canada before and after the reporting of the ENHANCE trial...
  8. ncbi request reprint Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis
    Mitesh Shah
    Divisions of Clinical Epidemiology and General Internal Medicine, McGill University Health Center, Montreal, Quebec, Canada M S, M A T, NE R, H B, L P _ Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, CA C A J Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada V E Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital McGill University, Montreal, Quebec, Canada M J E Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada K H H Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Canada Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada J V T and Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada H G
    Circulation 129:1196-203. 2014
    ..Current observational studies on warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation (AF) undergoing dialysis found conflicting results...
  9. ncbi request reprint Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients
    Cynthia A Jackevicius
    University Health Network, Toronto, ON, Canada
    Pharmacoepidemiol Drug Saf 16:207-15. 2007
    ..To assess the degree of concordance between the information (drug quantity, days' supply, and daily dose) recorded on hospital discharge prescriptions and what appears in a public drug insurance electronic claims database...
  10. doi request reprint Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction
    Cynthia A Jackevicius
    University Health Network and Department of Health Policy, Management, and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    Circulation 117:1028-36. 2008
    ..Our objectives were to characterize, to determine factors of, and to measure outcomes associated with primary nonadherence after AMI...
  11. doi request reprint Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study
    Noah M Ivers
    Family Practice Health Centre, Women s College Hospital, Toronto, Ontario, Canada Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada Electronic address
    Can J Cardiol 29:1408-14. 2013
    ..Patient adherence to cardiac secondary prevention medications declines over time. We examined whether the length of the initial prescription at hospital discharge after coronary angiography would be associated with long-term adherence...
  12. ncbi request reprint Routine use of glycoprotein IIb/IIIa inhibitor therapy is associated with an improved in-hospital outcome after percutaneous coronary intervention: Insights from a large, prospective, single-centre registry
    Cynthia A Jackevicius
    University Health Network, Toronto, Ontario
    Can J Cardiol 21:27-32. 2005
    ..Clinical trials have demonstrated the benefit of glycoprotein IIb/IIIa inhibitors (GPIs) with stenting in the setting of percutaneous coronary intervention (PCI) in reducing adverse cardiac outcomes...
  13. doi request reprint Use of aspirin and clopidogrel after coronary artery bypass graft surgery
    Noelle de Leon
    College of Pharmacy, Western University of Health Sciences, Pomona, CA, USA
    Ann Pharmacother 46:678-87. 2012
    ..To evaluate the evidence for the use of dual antiplatelet therapy (DAPT) with aspirin and clopidogrel following coronary artery bypass graft (CABG) surgery...
  14. doi request reprint Drug interaction between clopidogrel and proton pump inhibitors
    Tina J Liu
    Department of Pharmacy Practice, College of Pharmacy, Western University of Health Sciences, Pomona, California 91766, USA
    Pharmacotherapy 30:275-89. 2010
    ..Careful risk-benefit assessment is required before prescribing PPIs for individual patients taking dual antiplatelet therapy. More evidence from randomized controlled trials is needed to clarify this drug interaction dilemma...
  15. pmc A monograph assignment as an integrative application of evidence-based medicine and pharmacoeconomic principles
    Anandi V Law
    College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766, USA
    Am J Pharm Educ 75:1. 2011
    ..To describe the development and assessment of monographs as an assignment to incorporate evidence-based medicine (EBM) and pharmacoeconomic principles into a third-year pharmacoeconomic course...
  16. doi request reprint When choosing statin therapy: the case for generics
    Jonas B Green
    Cedars Sinai Medicine, Department of Medicine, Cedars Sinai Health System, Los Angeles, CA 90049, USA
    JAMA Intern Med 173:229-32. 2013
    ..In this article, we review the evidence supporting the choice of generic statins...
  17. ncbi request reprint Adherence with statin therapy in elderly patients with and without acute coronary syndromes
    Cynthia A Jackevicius
    Department of Health Policy, Management, and Evaluation, Pharmacy Department and Women s Health Program, University Health Network Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4
    JAMA 288:462-7. 2002
    ..Research prior to these trials of older lipid-lowering agents demonstrated low levels of 1-year adherence...
  18. doi request reprint Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years
    Dennis T Ko
    Institute for Clinical Evaluative Sciences, Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    Circ Cardiovasc Interv 3:140-7. 2010
    ..The incidence of late bleeding after PCI, its independent predictors, and its prognostic importance in clinical practice has not been fully addressed...
  19. doi request reprint Key articles related to complementary and alternative medicine in cardiovascular disease: part 1
    Sheryl L Chow
    Department of Pharmacy Practice and Administration, Western University of Health Sciences, Pomona, CA 91766, USA
    Pharmacotherapy 30:109. 2010
    ..Based on the numerous published reports available on this topic, this bibliography, as part 1 of 2, focuses on the efficacy of CAM therapy in cardiovascular disease...
  20. pmc The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention
    Jessica M Ma
    Pharmacy Department, Toronto East General Hospital, Canada
    Can J Cardiol 22:419-23. 2006
    ....
  21. ncbi request reprint Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery
    Doret K F Cheng
    General Medicine, Mount Sinai Hospital, Toronto, Ontario
    Can J Cardiol 20:223-8. 2004
    ..Eptifibatide and tirofiban appear to have favourable safety profiles compared with abciximab in the setting of emergency or urgent CABG after failed PCI...
  22. ncbi request reprint Acute treatment of myocardial infarction in Canada 1999-2002
    Cynthia A Jackevicius
    Pharmacy Department, University Health Network Toronto General Hospital, Toronto, Ontario M5G 2C4
    Can J Cardiol 21:145-52. 2005
    ..Therapy for management of acute myocardial infarction (AMI) varies according to patient, prescriber and geographical characteristics...
  23. ncbi request reprint Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001
    Cynthia A Jackevicius
    Pharmacy Department, University Health Network Toronto General Hospital, Toronto, Ontario, Canada
    Can J Cardiol 19:1359-66. 2003
    ..There is increasing interest in studying trends in drug utilization because drug costs are the fastest growing sector of the health care system...
  24. ncbi request reprint Association between ACE inhibitors and acute pancreatitis in the elderly
    Roger M S Cheng
    Princess Margaret Hospital, Toronto, Ontario, Canada
    Ann Pharmacother 37:994-8. 2003
    ..At present, no epidemiologic studies examining the potential association between ACE inhibitors and acute pancreatitis have been identified...
  25. pmc Indicators of quality of care for patients with acute myocardial infarction
    Jack V Tu
    The Institute for Clinical Evaluative Sciences, Toronto, Ont
    CMAJ 179:909-15. 2008
    ..We undertook this initiative to develop an updated set of evidence-based indicators to measure and improve the quality of care for this patient population...
  26. ncbi request reprint Use of OTC and herbal products in patients with cardiovascular disease
    Chantal Pharand
    Faculty of Pharmacy, Université de Montréal and Hôpital du Sacré Coeur de Montréal, Montreal, Quebec, Canada
    Ann Pharmacother 37:899-904. 2003
    ..The use of nonprescription and herbal products by the public is rising, resulting in an increased potential for adverse reactions or drug interactions in cardiac patients...
  27. ncbi request reprint The importance of in-hospital statin therapy for patients with acute coronary syndromes
    Fran L Paradiso-Hardy
    Department of Pharmacy, Sunnybrook and Women s College Health Sciences Centre, Faculty of Pharmacy, University of Toronto, Ontario, Canada
    Pharmacotherapy 23:506-13. 2003
    ..Various strategies have been developed to aid in the implementation of in-hospital lipid-lowering therapy. Pharmacists can play a valuable role in optimizing drug therapy for dyslipidemia and ensuring long-term adherence...